177932-89-7
Chemical Structure
Mozenavir dimethanesulfonate
Synonym(s): DMP-450 dimethanesulfonate
- CAS. Nr.: 177932-89-7
- Formula:C35H44N4O9S2
- Molecular Weight:728.88
IUPAC Name: (4R,5S,6S,7R)-1,3-bis(3-aminobenzyl)-4,7-dibenzyl-5,6-dihydroxy-1,3-diazepan-2-one methanesulfonate
InChIKey: HINZVVDZPLARRP-YSVIXOAZSA-N
SMILES: CS(=O)(O)=O.O[C@H]([C@H]([C@H](N(C1=O)CC2=CC(N)=CC=C2)CC3=CC=CC=C3)O)[C@@H](CC4=CC=CC=C4)N1CC5=CC(N)=CC=C5.CS(=O)(O)=O
Biological Activity: Mozenavir dimethanesulfonate (DMP-450 dimethanesulfonate) is an orally active cyclic urea HIV-1 protease inhibitor with an IC50 of 76 nM. Mozenavir dimethanesulfonate inhibits replication by targeting viral protease, blocks viral polyprotein processing, and induces the production of core-uncondensed, immature, non-infectious viral particles in chronically infected cells. Mozenavir dimethanesulfonate is applicable to research related to HIV infection[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Mozenavir dimethanesulfonate | Mozenavir dimethanesulfonate (DMP-450 dimethanesulfonate) is an orally active cyclic urea HIV-1 protease inhibitor with an IC50 of 76 nM. Mozenavir dimethanesulfonate inhibits replication by targeting viral protease, blocks viral polyprotein processing, and induces the production of core-uncondensed, immature, non-infectious viral particles in chronically infected cells. Mozenavir dimethanesulfonate is applicable to research related to HIV infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
